The renowned drug hunter, the Washington insider, the MIT strategist: How did one low-profile biotech enlist a dream team of top biotech advisors?
When you’re heading up a fledgling biotech out to make a name for yourself in the middle of a wild industry boom, there’s one sure way to differentiate yourself that’s bound to attract universal nods.
It doesn’t involve lots of money — plenty of that going around — and it isn’t constrained by timelines.
You enlist some great scientists, and you put together a dream team of high-profile industry leaders to mentor you through the long and arduous process of drug development ahead.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.